SPONSOR
The First Affiliated Hospital of Nanchang University
Total Trials
3
Recruiting
3
Phases
N/A
The First Affiliated Hospital of Nanchang University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Advanced NSCLC, Colorectal Cancer (CRC).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Affiliated Hospital of Nanchang University
How many clinical trials has The First Affiliated Hospital of Nanchang University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by The First Affiliated Hospital of Nanchang University, of which 3 are actively recruiting participants. These trials cover conditions including Advanced NSCLC, Colorectal Cancer (CRC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Affiliated Hospital of Nanchang University research focus on?
The First Affiliated Hospital of Nanchang University clinical trials span Advanced NSCLC, Colorectal Cancer (CRC). Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a The First Affiliated Hospital of Nanchang University clinical trial?
To participate in a The First Affiliated Hospital of Nanchang University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Affiliated Hospital of Nanchang University trials with current recruitment status updated daily.
Clinical Trials by The First Affiliated Hospital of Nanchang University
NCT06752044
Recruiting
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
NCT06752057
Recruiting
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
NCT06751966
Recruiting
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Colorectal Cancer (CRC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology